Celecoxib pretreatment and nab-paclitaxel-associated acute pain syndrome in patients with breast cancer: a prospective, non-randomized controlled clinical study.

Int J Surg · 2026 · PMC12825703 · PMID 41056041

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

Across all four chemotherapy cycles, a decreasing trend in FACT-Ntx scores was observed in both the celecoxib and placebo groups.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.